IRadimed
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of IRadimed generated cash of $13,465,012, which is more than the previous year. Cash used in financing activities reached the amount of -$13,656,511 last year. Net change in cash is therefore -$8,198,666.
Cash Flow
| 2014 | 2.58M | -8.30M | 12.70M |
|---|---|---|---|
| 2015 | 7.64M | -61.46K | 2.32M |
| 2016 | 9.40M | -1.94M | -9.11M |
| 2017 | 3.41M | -1.02M | -1.90M |
| 2018 | 7.37M | 1.51M | 929.87K |
| 2019 | 10.23M | 3.20M | 2.02M |
| 2020 | 5.81M | 246.96K | 522.48K |
| 2021 | 11.25M | 648.24K | 24.42K |
| 2022 | 10.04M | -1.37M | -12.70M |
| 2023 | 13.46M | -8.00M | -13.65M |
IRMD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 57.96M | 61.99M | 50.06M | 43.48M | 28.02M | 18.20M | 17.71M | 19.36M | 9.45M | 2.46M |
Operating activities | ||||||||||
Net income | 17.19M | 12.82M | 9.32M | 1.36M | 9.63M | 6.30M | 499.76K | 7.21M | 7.52M | 2.05M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 765.18K | 670.67K | 1.40M | 1.33M | 1.24M | 1.10M | 1.30M | 248.29K | 223.94K | 149.05K |
Stock-based compensation expense | 2.18M | 1.39M | 1.45M | 3.96M | 1.85M | 0 | 2.45M | 1.84M | 1.22M | 724.06K |
| Deferred income tax benefit | 2.18M | 1.39M | 1.45M | 3.96M | 1.85M | 0 | 2.45M | 1.84M | 1.22M | 724.06K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 841.91K | -8.24M | -575.54K | 2.69M | -3.11M | -446.89K | -201.59K | 75.29K | -1.90M | 21.86K |
Inventories | 0 | -1.30M | -393.31K | -282.90K | 123.68K | -121.59K | -334.11K | -1.48M | -308.40K | -847.57K |
Accounts payable | -216.43K | 1.12M | 30.41K | -403.56K | 149.31K | 34.16K | -523.44K | 1.11K | 376.29K | 201.69K |
Cash generated by operating activities | 13.46M | 10.04M | 11.25M | 5.81M | 10.23M | 7.37M | 3.41M | 9.40M | 7.64M | 2.58M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -1.12M | -2.69M | -4.99M | 0 | -7.95M |
Investments In Property Plant And Equipment | -7.44M | -1.87M | -741.75K | -636.74K | -485.81K | -264.66K | -824.76K | -1.52M | -314.83K | -606.28K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 36.35K | 49.18K | 743.48K | 0 | 22.31K |
Cash generated by investing activities | -8.00M | -1.37M | 648.24K | 246.96K | 3.20M | 1.51M | -1.02M | -1.94M | -61.46K | -8.30M |
Financing activities | ||||||||||
Common Stock Issued | 176.74K | 146.70K | 623.24K | 1.73M | 2.49M | 1.23M | 0 | 0 | 597.50K | 14.49M |
Payments for dividends | -13.22M | -12.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -610.34K | -293.98K | -598.81K | -1.20M | -473.14K | -309.56K | -1.81M | -9.96M | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.33K |
Cash used in financing activities | -13.65M | -12.70M | 24.42K | 522.48K | 2.02M | 929.87K | -1.90M | -9.11M | 2.32M | 12.70M |
Net Change In Cash | -8.19M | -4.03M | 11.93M | 6.58M | 15.45M | 9.82M | 492.10K | -1.65M | 9.91M | 6.99M |
Cash at end of period | 49.76M | 57.96M | 61.99M | 50.06M | 43.48M | 28.02M | 18.20M | 17.71M | 19.36M | 9.45M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |